INFOSCUM.COM
Novo Slides as Amgen Fuels Obesity Drug Competition Fears - Bloomberg
Published Date:
5/3/2024
Source:
news.google.com
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Yahoo Finance
Amgen encouraged by preliminary data from weight-loss-drug trial, as stock jumps
MarketWatch
Amgen goes all in on injectable obesity drug as it scraps early-stage pill
STAT
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
CNBC
Read the Full Story Here
InfoScum.com